AbbVie Shares Dip Despite $10.25 Billion Trading Volume Ranking 76th in Market Activity

AbbVie (ABBV) shares fell 0.12% on June 20, 2025, with a trading volume of $10.25 billion, ranking 76th in the day's market activity.

The board of directors of AbbVie Inc. declared a quarterly cash dividend of $1.64 per share. This dividend is payable on August 15, 2025, to stockholders of record at the close of business on July 15, 2025. This announcement underscores AbbVie's commitment to returning value to its shareholders, as the company has increased its dividend by 310 percent since its inception in 2013. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

This dividend declaration is part of AbbVie's broader strategy to provide innovative medicines and solutions that address serious health issues. The company focuses on several key therapeutic areas, including immunology, oncology, neuroscience, and eye care, as well as products and services in its Allergan Aesthetics portfolio. AbbVie's mission is to have a remarkable impact on people's lives by delivering solutions that solve today's health challenges and address future medical needs.